ArticleTrials2026

Study protocol for a randomized, double-blind, placebo-controlled clinical trial of desidustat oral tablet in sickle cell disease: a phase IIa proof-of-concept evaluation.

Mayank Gangwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.